1.Environmental and Body Concentrations of Heavy Metals at Sites Near and Distant from Industrial Complexes in Ulsan, Korea
Joo Hyun SUNG ; Inbo OH ; Ahra KIM ; Jiho LEE ; Chang Sun SIM ; Cheolin YOO ; Sang Jin PARK ; Geun Bae KIM ; Yangho KIM
Journal of Korean Medical Science 2018;33(5):e33-
BACKGROUND: Industrial pollution may affect the heavy metal body burden of people living near industrial complexes. We determined the average concentrations of atmospheric heavy metals in areas close to and distant from industrial complexes in Korea, and the body concentrations of these heavy metals in residents living near and distant from these facilities. METHODS: The atmospheric data of heavy metals (lead and cadmium) were from the Regional Air Monitoring Network in Ulsan. We recruited 1,148 participants, 872 who lived near an industrial complex (“exposed” group) and 276 who lived distant from industrial complexes (“non-exposed” group), and measured their concentrations of blood lead, urinary cadmium, and urinary total mercury. RESULTS: The results showed that atmospheric and human concentrations of heavy metals were higher in areas near industrial complexes. In addition, residents living near industrial complexes had higher individual and combined concentrations (cadmium + lead + mercury) of heavy metals. CONCLUSION: We conclude that residents living near industrial complexes are exposed to high concentrations of heavy metals, and should be carefully monitored.
Body Burden
;
Cadmium
;
Environmental Exposure
;
Humans
;
Korea
;
Metals, Heavy
;
Ulsan
2.Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016.
Deog Young KIM ; Yun Hee KIM ; Jongmin LEE ; Won Hyuk CHANG ; Min Wook KIM ; Sung Bom PYUN ; Woo Kyoung YOO ; Suk Hoon OHN ; Ki Deok PARK ; Byung Mo OH ; Seong Hoon LIM ; Kang Jae JUNG ; Byung Ju RYU ; Sun IM ; Sung Ju JEE ; Han Gil SEO ; Ueon Woo RAH ; Joo Hyun PARK ; Min Kyun SOHN ; Min Ho CHUN ; Hee Suk SHIN ; Seong Jae LEE ; Yang Soo LEE ; Si Woon PARK ; Yoon Ghil PARK ; Nam Jong PAIK ; Sam Gyu LEE ; Ju Kang LEE ; Seong Eun KOH ; Don Kyu KIM ; Geun Young PARK ; Yong Il SHIN ; Myoung Hwan KO ; Yong Wook KIM ; Seung Don YOO ; Eun Joo KIM ; Min Kyun OH ; Jae Hyeok CHANG ; Se Hee JUNG ; Tae Woo KIM ; Won Seok KIM ; Dae Hyun KIM ; Tai Hwan PARK ; Kwan Sung LEE ; Byong Yong HWANG ; Young Jin SONG
Brain & Neurorehabilitation 2017;10(Suppl 1):e11-
“Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” is the 3rd edition of clinical practice guideline (CPG) for stroke rehabilitation in Korea, which updates the 2nd edition published in 2014. Forty-two specialists in stroke rehabilitation from 21 universities and 4 rehabilitation hospitals and 4 consultants participated in this update. The purpose of this CPG is to provide optimum practical guidelines for stroke rehabilitation teams to make a decision when they manage stroke patients and ultimately, to help stroke patients obtain maximal functional recovery and return to the society. The recent two CPGs from Canada (2015) and USA (2016) and articles that were published following the 2nd edition were used to develop this 3rd edition of CPG for stroke rehabilitation in Korea. The chosen articles' level of evidence and grade of recommendation were decided by the criteria of Scotland (2010) and the formal consensus was derived by the nominal group technique. The levels of evidence range from 1++ to 4 and the grades of recommendation range from A to D. Good Practice Point was recommended as best practice based on the clinical experience of the guideline developmental group. The draft of the developed CPG was reviewed by the experts group in the public hearings and then revised. “Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” consists of ‘Chapter 1; Introduction of Stroke Rehabilitation’, ‘Chapter 2; Rehabilitation for Stroke Syndrome, ‘Chapter 3; Rehabilitation for Returning to the Society’, and ‘Chapter 4; Advanced Technique for Stroke Rehabilitation’. “Clinical Practice Guideline for Stroke Rehabilitation in Korea 2016” will provide direction and standardization for acute, subacute and chronic stroke rehabilitation in Korea.
Canada
;
Consensus
;
Consultants
;
Humans
;
Korea*
;
Practice Guidelines as Topic
;
Rehabilitation*
;
Scotland
;
Specialization
;
Stroke*
3.Clinicopathologic characteristics and prognosis of remnant gastric cancer
Tae Geun KWON ; Kwang Hee KIM ; Sang Hyuk SEO ; In Seob JEONG ; Yo Han PARK ; Min Sung AN ; Tae Kwon HA ; Ki Beom BAE ; Chang Soo CHOI ; Sang Hoon OH
Korean Journal of Clinical Oncology 2017;13(2):83-91
PURPOSE: Remnant gastric cancer is defined as a malignant tumor developing on the remnant side of stomach after partial gastrectomy. The purpose of this study is to evaluate the clinical characteristics and prognosis of remnant gastric cancer according to the cause and the reconstruction method of previous surgery.METHODS: Between January 2007 and February 2016, we analyzed 39 patients with their medical records who were diagnosed as remnant gastric cancer and underwent gastrectomy at Inje University Busan Paik Hospital.RESULTS: In the comparison of malignant disease (MD) and benign diseases (BD) group, the Billroth I:Billroth II ratio was 52.2% and 12.5%. The time interval from the previous operation to the diagnosis of remnant gastric cancer (RGC) was shorter in the MD group than in the BD group (6.6±6.04 vs. 34.7±10.12 years). Comparing B1 and B2 group, the proportion of patients previously undergone surgery due to MD was 85.7% and 44%. The time interval was higher in the B1 group than in the B2 group (8.0±8.78 vs. 23.8±16.48 years). Analyzing prognostic factors of survival, age and the presence of symptoms at the time of RGC diagnosis, and curability of surgery had a significant effect on the survival of the patients (P=0.032, hazard ratio [HR]=5.241, 95% confidence interval [CI], 1.158–23.723; P=0.005, HR=5.086, 95% CI, 1.642–15.750; P=0.034, HR=3.165, 95% CI, 1.088–9.208).CONCLUSION: Patients who underwent partial gastrectomy for benign or MD require regular endoscopic follow-up and appropriate surgical approach is essential for the treatment of RGC.
Busan
;
Diagnosis
;
Follow-Up Studies
;
Gastrectomy
;
Humans
;
Medical Records
;
Methods
;
Prognosis
;
Stomach
;
Stomach Neoplasms
4.Characterization of Salmonella spp. Clinical Isolates in Gyeongsangbuk-do Province, 2012 to 2013.
Oh Geun KWEON ; Jin Seok KIM ; Gou Ok KIM ; Chang Il LEE ; Kwang Hyeon JEONG ; Junyoung KIM
Annals of Clinical Microbiology 2014;17(2):50-57
BACKGROUND: Extended-spectrum cephalosporins and fluoroquinolones are important antimicrobials for treating invasive salmonellosis, and emerging resistance to these antimicrobials is of paramount concern. METHODS: A total of 30 Salmonella spp. clinical isolates recovered in Gyeongsangbuk-do from 2012 to 2013 were characterized using antibiotic resistance profiles and pulsed-field gel electrophoresis (PFGE). RESULTS: A high prevalence of multidrug-resistant isolates, mainly showing an ampicillin, nalidixic acid, chloramphenicol resistance pattern, was observed. Four extended-spectrum beta-lactamase (ESBL)-producing isolates (3 CTX-M-15 isolates and 1 CTX-M-27 isolate) were found. The bla(CTX-M-27) gene was carried by an IncF conjugative plasmid in the S. Infantis isolate. The bla(CTX-M-15) gene were carried by an IncF (2 isolates) or IncHI2 (1 isolate) conjugative plasmid in S. Enteritidis. In addition, a single mutation of GyrA, Ser83Thr (1 isolates), Asp87Tyr (9 isolates), Asp87Gly (4 isolates), and Asp87Leu (3 isolates), was detected in nalidixic acid-resistant Salmonella spp. isolates. XbaI PFGE analysis of all isolates revealed more than 19 different pulsotypes. The most common S. Enteritidis PFGE pattern (SEGX01.003) was associated with a larger number of cases of invasive salmonellosis than all other patterns. CONCLUSION: The information from our study can assist in source attribution, outbreak investigations, and tailoring of interventions to maximize disease prevention.
Ampicillin
;
beta-Lactamases
;
Cephalosporins
;
Chloramphenicol Resistance
;
Drug Resistance
;
Drug Resistance, Microbial
;
Electrophoresis, Gel, Pulsed-Field
;
Fluoroquinolones
;
Gyeongsangbuk-do
;
Nalidixic Acid
;
Plasmids
;
Prevalence
;
Salmonella Infections
;
Salmonella*
5.Recovery from a Complicated Case of Central Pontine and Extrapontine Myelinolysis by Dopaminergic Treatment: One-Year Follow-up: A Case Report.
Yu Jung SEO ; Sun IM ; Chang Hoon OH ; Geun Young PARK ; Sae Byuk KO ; Yu Jin LEE
Brain & Neurorehabilitation 2014;7(2):126-130
Central pontine and extrapontine myelinolysis are well-recognized osmotic demyelination syndromes related to the rapid correction of hyponatremia, chronic alcoholism, and malnutrition. They are reported to show brain stem signs and various movement disorders. A 58-year-old man with a history of chronic alcoholism was admitted for dysarthria, dysphagia, and gait disturbance that had developed five days after a right forearm cellulitis. Magnetic resonance imaging revealed demyelinating patterns in the central portion of the pons and both thalami. He showed severe extrapyramidal symptoms with truncal swaying and postural instability that resulted in severe gait disturbance. Postural instability showed little improvement after conventional physical therapy, but his symptoms markedly improved after five days of dopamine administration. Cessation of dopamine agents was attempted two times, but postural instability and gait disturbance recurred. Therefore, medication was continued for one year. The patient showed stable gait and no further deterioration of postural instability during dopamine therapy.
Alcoholism
;
Brain Stem
;
Cellulitis
;
Deglutition Disorders
;
Demyelinating Diseases
;
Dopamine
;
Dopamine Agents
;
Dysarthria
;
Follow-Up Studies*
;
Forearm
;
Gait
;
Humans
;
Hyponatremia
;
Magnetic Resonance Imaging
;
Malnutrition
;
Middle Aged
;
Movement Disorders
;
Myelinolysis, Central Pontine*
;
Pons
6.Validation of Group B Borderline Resectable Pancreatic Cancer: Retrospective Analysis.
Tak Geun OH ; Moon Jae CHUNG ; Seungmin BANG ; Seung Woo PARK ; Jae Bok CHUNG ; Si Young SONG ; Jinsil SEONG ; Chang Moo KANG ; Woo Jung LEE ; Jeong Youp PARK
Gut and Liver 2014;8(5):557-562
BACKGROUND/AIMS: Among borderline resectable pancreatic cancer (BRPC), group B BRPC patients have findings that are suggestive but not diagnostic of metastasis. In this study, we attempted to validate whether group B could truly be categorized as a borderline resectable group. METHODS: We placed the BRPC patients into group A or group B. The survival outcomes were compared between the groups. RESULTS: A total of 53 patients with pancreatic adenocarcinoma was classified as either group A or B borderline resectable. In group A, 23 (60.5%) of 38 patients underwent pancreatectomy after concurrent chemoradiotherapy or chemotherapy, but in group B, only five (33.3%) of 15 patients underwent pancreatectomy, mainly because of the progression of suspected distant metastasis. There was a significant difference in overall survival (OS) between group A and B patients (median OS, 21.2 months vs 10.2 months, respectively; p=0.007). Of the patients who underwent pancreatectomy, group B had a higher recurrence rate compared to group A (recurrence rate: 11 of 23 patients [47.8%] vs five of five patients [100%], respectively; p=0.033). CONCLUSIONS: This report is the first to validate the definition of BPRC. Group B had much worse outcomes, and whether group B BRPC can be categorized as BRPC together with group A is questionable.
Adenocarcinoma/classification/mortality/pathology/surgery
;
Adult
;
Aged
;
Aged, 80 and over
;
Chemoradiotherapy
;
Female
;
Humans
;
Male
;
Middle Aged
;
Neoplasm Metastasis
;
Neoplasm Recurrence, Local
;
Pancreatectomy
;
Pancreatic Neoplasms/*classification/mortality/pathology/*surgery
;
Retrospective Studies
;
Treatment Outcome
7.Modifiers of TGF-beta1 effector function as novel therapeutic targets of pulmonary fibrosis.
Chang Min LEE ; Jin Wook PARK ; Won Kyung CHO ; Yang ZHOU ; Boram HAN ; Pyoung Oh YOON ; Jeiwook CHAE ; Jack A ELIAS ; Chun Geun LEE
The Korean Journal of Internal Medicine 2014;29(3):281-290
Pulmonary fibrosis is a fatal progressive disease with no effective therapy. Transforming growth factor (TGF)-beta1 has long been regarded as a central mediator of tissue fibrosis that involves multiple organs including skin, liver, kidney, and lung. Thus, TGF-beta1 and its signaling pathways have been attractive therapeutic targets for the development of antifibrotic drugs. However, the essential biological functions of TGF-beta1 in maintaining normal immune and cellular homeostasis significantly limit the effectiveness of TGF-beta1-directed therapeutic approaches. Thus, targeting downstream mediators or signaling molecules of TGF-beta1 could be an alternative approach that selectively inhibits TGF-beta1-stimulated fibrotic tissue response while preserving major physiological function of TGF-beta1. Recent studies from our laboratory revealed that TGF-beta1 crosstalk with epidermal growth factor receptor (EGFR) signaling by induction of amphiregulin, a ligand of EGFR, plays a critical role in the development or progression of pulmonary fibrosis. In addition, chitotriosidase, a true chitinase in humans, has been identified to have modulating capacity of TGF-beta1 signaling as a new biomarker and therapeutic target of scleroderma-associated pulmonary fibrosis. These newly identified modifiers of TGF-beta1 effector function significantly enhance the effectiveness and flexibility in targeting pulmonary fibrosis in which TGF-beta1 plays a significant role.
Animals
;
Drug Design
;
Hexosaminidases/antagonists & inhibitors/metabolism
;
Humans
;
Lung/*drug effects/metabolism/pathology
;
Molecular Targeted Therapy
;
Pulmonary Fibrosis/*drug therapy/metabolism/pathology
;
Receptor Cross-Talk
;
Receptor, Epidermal Growth Factor/antagonists & inhibitors/metabolism
;
Receptors, Transforming Growth Factor beta/antagonists & inhibitors/metabolism
;
Signal Transduction
;
Transforming Growth Factor beta1/*antagonists & inhibitors/metabolism
8.Esophageal Pyogenic Granuloma: Endosonographic Findings and Endoscopic Treatments.
Hyeog Gyu SEOUNG ; Gwang Ha KIM ; Geun Am SONG ; Ji Hye KIM ; Min Young OH ; Jeong Cheon CHOI ; Jung Hee KOH ; Chang Jun PARK
Clinical Endoscopy 2013;46(1):81-84
Pyogenic granuloma is a benign inflammatory vascular lesion, mainly found in the skin and oral mucosa. A few cases of pyogenic granuloma in the gastrointestinal tract have been reported, and the esophagus was the main site in these cases. These patients were diagnosed with pyogenic granuloma after they underwent upper endoscopy and biopsy. Endoscopic resection is a favorable treatment option for esophageal pyogenic granuloma. Recently, we observed characteristic endosonographic findings in two cases with esophageal pyogenic granuloma, which were then treated successfully by endoscopic resection.
Biopsy
;
Endoscopy
;
Endosonography
;
Esophagus
;
Gastrointestinal Tract
;
Granuloma, Pyogenic
;
Humans
;
Mouth Mucosa
;
Skin
9.Occurrence and characterization of oseltamivir-resistant influenza virus in children between 2007-2008 and 2008-2009 seasons.
Seoung Geun KIM ; Yoon Ha HWANG ; Yung Hae SHIN ; Sung Won KIM ; Woo Sik JUNG ; Sung Mi KIM ; Jae Min OH ; Na Young LEE ; Mun Ju KIM ; Kyung Soon CHO ; Yeon Gyeong PARK ; Sang Kee MIN ; Chang Kyu LEE ; Jun Sub KIM ; Chun KANG ; Joo Yeon LEE ; Man Kyu HUH ; Chang Hoon KIM
Korean Journal of Pediatrics 2013;56(4):165-175
PURPOSE: There was a global increase in the prevalence of oseltamivir-resistant influenza viruses during the 2007-2008 influenza season. This study was conducted to investigate the occurrence and characteristics of oseltamivir-resistant influenza viruses during the 2007-2008 and 2008-2009 influenza seasons among patients who were treated with oseltamivir (group A) and those that did not receive oseltamivir (group B). METHODS: A prospective study was conducted on 321 pediatric patients who were hospitalized because of influenza during the 2007-2008 and 2008-2009 influenza seasons. Drug resistance tests were conducted on influenza viruses isolated from 91 patients. RESULTS: There was no significant difference between the clinical characteristics of groups A and B during both seasons. Influenza A/H1N1, isolated from both groups A and B during the 2007-2008 and 2008-2009 periods, was not resistant to zanamivir. However, phenotypic analysis of the virus revealed a high oseltamivir IC50 range and that H275Y substitution of the neuraminidase (NA) gene and partial variation of the hemagglutinin (HA) gene did not affect its antigenicity to the HA vaccine even though group A had a shorter hospitalization duration and fewer lower respiratory tract complications than group B. In addition, there was no significant difference in the clinical manifestations between oseltamivir-susceptible and oseltamivir-resistant strains of influenza A/H1N1. CONCLUSION: Establishment of guidelines to efficiently treat influenza with oseltamivir, a commonly used drug for treating influenza in Korean pediatric patients, and a treatment strategy with a new therapeutic agent is required.
Child
;
Drug Resistance
;
Hemagglutinins
;
Hospitalization
;
Humans
;
Influenza, Human
;
Inhibitory Concentration 50
;
Neuraminidase
;
Orthomyxoviridae
;
Oseltamivir
;
Prevalence
;
Prospective Studies
;
Respiratory System
;
Seasons
;
Viruses
;
Zanamivir
10.Paper-Based Analytical Device for Quantitative Urinalysis.
Seong Geun JEONG ; Jongmin KIM ; Jin Oh NAM ; Young Shin SONG ; Chang Soo LEE
International Neurourology Journal 2013;17(4):155-161
Paper-based analytical devices are fluidic chips fabricated with extremely inexpensive materials, namely paper, thereby allowing their use as a zero-cost analytical device in third-world countries that lack access to expensive diagnostic infrastructures. The aim of this review is to discuss: (1) microfluidic paper-based analytical devices (microPADs) for quantitative analysis, (2) fabrication of two- or three-dimensional microPADs, (3) analytical methods of microPADs, and (4) our opinions regarding the future applications of microPADs for quantitative urinalysis.
Developing Countries
;
Methods
;
Microfluidics
;
Urinalysis*

Result Analysis
Print
Save
E-mail